Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,424.85 162.29 1.00%
S&P 500 1,862.31 19.33 1.05%
NASDAQ 4,086.22 52.06 1.29%
Ticker Volume Price Price Delta
STOXX 50 3,139.26 47.74 1.54%
FTSE 100 6,584.17 42.56 0.65%
DAX 9,317.82 144.11 1.57%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,761.01 65.00 0.29%

Medivation Announces Participation at Upcoming Investor


Medivation Announces Participation at Upcoming Investor Conferences

SAN FRANCISCO, CA -- (Marketwire) -- 11/29/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:


 
--  David Hung, M.D., president and chief executive officer, will present
    at the Deutsche Bank BioFEST Conference on December 3 at 9:35am
    Eastern Time in Boston, MA.
--  David Hung, M.D., president and chief executive officer, will present
    at the JP Morgan Healthcare Conference on January 7 at 4:30pm Pacific
    Time in San Francisco, CA.

About Medivation Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts: Patrick Machado Chief Business & Financial Officer (415) 829-4101

Anne Bowdidge Sr. Director Investor Relations (650) 218-6900

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement